Celebrating 35 Years

Identification and Development of Therapeutic Targets in Neurofibromatosis Type 2


At NF Midwest’s annual family symposium held on October 12, 2013, Dr. Joseph Kissil from the Scripps Institute in Florida spoke about current research on the identification and development of therapeutic targets in neurofibromatosis type 2. As part of our continuing effort to keep the neurofibromatosis community iNFormed we have published the transcript from that session.

GET TRANSCRIPT PDF

<< Search Our Articles

Get the Latest NF News & Updates

Sign up for our blog and always be up-to-date with Neurofibromatosis


Visit Us
Follow Me
Tweet
Share